Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow-derived mesenchymal stem cells on 3D scaffold for knee cartilage defects
2017-004143-21Phase 2Active
- Sponsor
- Bioinova
- Start
- Aug 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of autologous bone marrow derived mesenchymal stromal cells in cartilage defect of knee and chondral knee defect (2 arms), sponsored by Bioinova. Primary endpoint: Lysholm knee score change. Started Aug 2018; status: active.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
cartilage defect of kneechondral knee defect
Beyond the preview
Go deeper on 2017-004143-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004143-21.